Live CSL updates

Live CSL news coverage of developments with the latest updates. Stay on top of latest CSL news stories and find out what just happened, what is going on with CSL. The latest real-time news updates and headlines on CSL
Dr Michelle Boyle awarded prestigious Snow Medical Fellowship
Bridge Management Resource Critical in Devonport Collision
Robot Aids SynecocultureTM Farming with Sowing, Pruning, Harvesting
Canadian Coast Guard Icebreaking Supports Midland Shipping
Starpharma announces appointment of chief financial officer
Australian Cell and Gene Catalyst takes step forward
CSL’s Garadacimab Trial Yields Positive Results
Houstonians Weigh In on Bleeding Out Trauma Patient Study
Europe approves CSL’s first gene therapy for Haemophilia B
CSL Plasma Collections Reach Pre-Pandemic Highs Thanks to Key Franchise
WA Gov to Extend Partnership with Brandon BioCatalyst
Ide-Cel CAR T Therapy Offers Hope for Treating Recurrent Myeloma
Antibody May Treat Serious Liver Disease: Study
Positive CHMP Opinion Etranacogene Dezaparvovec
CSL announces appointment of its new CEO and managing director
CSL Announces Next CEO & Managing Director
CSL Closing of Arcturus Therapeutics Agreement
CSL’s Novel Gene Therapy HEMGENIX Demonstrates Durable Protection and Sustained Factor IX Activity Levels for People Living
CSL opens its new ‘Australian Plasma Fractionation Facility’ in Melbourne
New Australian Plasma Fractionation Facility
WEHI scientist recognised with CSL Florey Medal for malaria research
Debunking autism myths rewarded with national prize
Why autistic children are more likely to have gut problems
Lifetime investigating malaria leads to drugs that push back on resistance… And CSL Florey Medal
CSL secures US approval for breakthrough one-time haemophilia gene therapy
Research estimates lifetime benefit of combination therapy in patients with kidney disease without diabetes
U.S. Food and Drug Administration approves CSL’s HEMGENIX , first gene therapy for hemophilia B
Dapagliflozin is not only clinically effective, but also cost effective in patients with chronic kidney disease
New AusBiotech Board fit for era
Cicada Innovations to operate new biotech incubator to drive translation of world class medical research
CSL R and D Day 2022
Cicada to operate new biotech incubator
CSL Enters Licensing Agreement
CSL and Translational Sciences enter Agreement
New HQ Earns Sustainability Credentials
Dr Michelle Boyle named 2023 CSL Centenary Fellow
Fighting malaria and chronic bowel disease: $2.5 million CSL Centenary Fellowships awarded
2023 CSL Centenary Fellowships awarded
Pollen does more than make you sneeze
CSL announces seven recipients of ‘Global Research Acceleration Initiative’ awards
CSL RAI Awardees Announced
Bernadette Murdoch to lead CSL’s Reputation CoE
CSL presents new research and development center in Marburg, Germany
AusBiotech 2022 programme launched
CSL grant delivers big support for Hume not-for-profit
Transplant candidates’ thoughts about tradeoffs of shorter wait time for lower quality kidneys
CSL starts planning to submit new antibody treatment
Academy archive digitisation project boosted by generous donation